Literature DB >> 17301947

Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.

Heidi Y Shi1, Lewis Joe Stafford, Zhisheng Liu, Mingyao Liu, Ming Zhang.   

Abstract

Rac1 and Cdc42 are members of the Rho family of small GTPases that play essential roles in diverse cellular functions, including cell migration. The activities of these Rho family proteins are controlled by growth factor receptor activation and cell-ECM interactions. Here, we show that maspin, a well-documented tumor suppressor gene, also controls cell motility through inhibiting Rac1/Cdc42 activity. Using the GST-PAK and GST-Rho binding protein pull-down assays for GTP-bound Rac1, Cdc42, and RhoA, we showed that treatment of MDA-MB-231 tumor cells with recombinant maspin for a short time period significantly inhibited the activity of Rac1 and Cdc42, but not RhoA. The reactive site loop (RSL) within maspin protein is the functional domain involved in the inhibition. Maspin mutants with the RSL deleted or a point mutation in the RSL region lost their inhibitory activity. We further examined the ability of maspin to inhibit Rac1- and Cdc42-mediated signaling pathways and transcription factors. Treatment of MDA-MB-231 cells with maspin led to the inhibition of JNK kinase activity as assayed by immuno-kinase assays. In addition, the AP-1 transcription activity downstream of JNK kinase pathway was also reduced. Together, we have identified Rac1 and Cdc42 as the downstream targets that mediate the inhibition of mammary tumor cell migration by maspin. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301947     DOI: 10.1002/cm.20187

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  15 in total

1.  Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.

Authors:  Brenda L Montalvo-Ortiz; Linette Castillo-Pichardo; Eliud Hernández; Tessa Humphries-Bickley; Alina De la Mota-Peynado; Luis A Cubano; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

2.  Clinicopathological pattern and Annexin A2 and Cdc42 status in patients presenting with differentiation and lymphnode metastasis of esophageal squamous cell carcinomas.

Authors:  Jun-Guo Feng; Qing Liu; Xu Qin; Yue-Hua Geng; Shu-Tao Zheng; Tao Liu; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

3.  G-helix of maspin mediates effects on cell migration and adhesion.

Authors:  Lorna Ravenhill; Laura Wagstaff; Dylan R Edwards; Vincent Ellis; Rosemary Bass
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 4.  Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors.

Authors:  Ulrich H Weidle; Fabian Birzele; Georg Tiefenthaler
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

5.  Maspin (SERPINB5) is an obligate intracellular serpin.

Authors:  Sonia S Y Teoh; James C Whisstock; Phillip I Bird
Journal:  J Biol Chem       Date:  2010-02-01       Impact factor: 5.157

6.  Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential.

Authors:  Yu Zhang; Melanie Köllmer; Jason S Buhrman; Mary Y Tang; Richard A Gemeinhart
Journal:  Peptides       Date:  2014-06-23       Impact factor: 3.750

7.  Tumor-suppressive maspin functions as a reactive oxygen species scavenger: importance of cysteine residues.

Authors:  Nitin Mahajan; Heidi Y Shi; Thomas J Lukas; Ming Zhang
Journal:  J Biol Chem       Date:  2013-03-07       Impact factor: 5.157

8.  Binding of extracellular maspin to beta1 integrins inhibits vascular smooth muscle cell migration.

Authors:  Rosemary Bass; Laura Wagstaff; Lorna Ravenhill; Vincent Ellis
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

9.  Proteinase-activated receptors differentially modulate in vitro invasion of human pancreatic adenocarcinoma PANC-1 cells in correlation with changes in the expression of CDC42 protein.

Authors:  Liora Segal; Liora S Katz; Monica Lupu-Meiri; Hagit Shapira; Judith Sandbank; Marvin C Gershengorn; Yoram Oron
Journal:  Pancreas       Date:  2014-01       Impact factor: 3.327

10.  Promoter Hypomethylation of Maspin Inhibits Migration and Invasion of Extravillous Trophoblast Cells during Placentation.

Authors:  Xinwei Shi; Hao Liu; Jing Cao; Qing Liu; Guiju Tang; Wanlu Liu; Haiyi Liu; Dongrui Deng; Fuyuan Qiao; Yuanyuan Wu
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.